Skip to content
Home/Companies/Biotech/Alderaan Biotechnology

Alderaan Biotechnology

Biotech·France·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Alderaan Biotechnology?

Alderaan Biotechnology is a French Biotech company, currently owned by AdBio Partners since 2020.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
AdBio Partners
Investor
AdBio Partners
AFB Seed-Fund · 2017 · VC

Key facts

HQFrance
SectorBiotech

More from AFB Seed-Fund

Other portfolio companies in the same fund.

ARTHEx Biotech
ARTHEx Biotech
Active
BiotechSpain· 2020
GAMUT Therapeutics
Exited 2021
BiotechFrance· 2020
to SparingVision
Kalsiom
Kalsiom
Active
BiotechFrance· 2020
Wellium
Active
HealthcareFrance· 2020
Agomab Therapeutics
Agomab Therapeutics
Exited 2026
BiotechBelgium· 2019
to Nasdaq (IPO)
SparingVision
SparingVision
Active
BiotechFrance· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Alderaan Biotechnology?

Alderaan Biotechnology is currently owned by AdBio Partners, through AFB Seed-Fund, since 2020.

When did AdBio Partners acquire Alderaan Biotechnology?

AdBio Partners acquired Alderaan Biotechnology in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue